Investor Sues Drug Company, Others Over Involvement In Price-Fixing Scheme
NEW YORK — A specialty pharmaceutical company and several of its current and former officers and directors concealed their involvement in an illegal generic drug price-fixing scheme in violation of federal...To view the full article, register now.
Already a subscriber? Click here to view full article